-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In 2022, the situation at home and abroad will be complex and changeable, and the global economic development and scientific and technological exchanges will face major setbacks and challenges
.
Innovation-driven and technology-led have become key breakthroughs
in the great changes in development.
The more tight the time, the more we must adhere to the problem-oriented decision-making of scientific and technological development, stabilize the economic disk with the efficiency of scientific and technological achievements, and accelerate the cultivation of innovation highlands into economic highlands
.
Looking at more than 50 science and technology policies issued from the central to the local government in 2022, focusing on important points such as funds, talents, and markets, policies will be accurately put into the whole chain of technology transformation, from laboratories, production lines to the use end, efficiently activating the driving force
of innovation and development.
As an important battlefield in the "four aspects" of scientific and technological innovation, 2022
The salient features of science and technology policies in the pharmaceutical field are that they comprehensively focus on the transformation of scientific and technological achievements: strengthen the role of early R&D guidance funds, reform the talent evaluation mechanism and guarantee the autonomy of achievement transformation, accelerate the market-oriented reform of technical elements, and encourage results-oriented source innovation
.
Innovative entities such as medical research institutions, clinicians, and research hospitals are providing more sufficient source water for new drug research and development
.
.
1.
In 2022, from the central to the local level, more than 50 achievement transformation policies will be intensively released
In recent years, China's basic research achievements have achieved explosive growth, but the transformation data of scientific and technological achievements is not optimistic
.
The annual conversion rate of medical scientific and technological achievements in China is less than 8%, which is lower than the average conversion rate of major scientific and technological achievements in all fields of 20%, and it is far lower than the ratio
of nearly 70% in the same field in the United States and Japan.
Therefore, it is urgent to accelerate the transformation and breakthrough
of scientific research activities from quantitative change to qualitative change, from basic theory to technology development.
of nearly 70% in the same field in the United States and Japan.
The report of the 20th National Congress of the Communist Party of China further emphasized the national strategy of improving the scientific and technological innovation system and realizing innovation-driven development, and pointed out key measures
such as "deepening the reform of the scientific and technological system, deepening the reform of scientific and technological evaluation, increasing diversified investment in science and technology, strengthening the legal protection of intellectual property rights, and forming a basic system to support comprehensive innovation".
In order to implement the spirit of the "20th National Congress", the central and local policies have accelerated the corresponding layout
.
According to incomplete statistics, in 2022, the central and local governments issued more than 50 policies to support the transformation of science and technology, which not only increased in number compared with previous years, but also showed new characteristics
of wide distribution, rich levels and a hundred flowers 。 From the distribution point of view, in addition to Beijing, Shanghai and other places, inland areas such as Inner Mongolia and Shanxi, as well as many third-tier cities and below, have issued corresponding policies, indicating that technology transformation has received widespread attention, and the spark of achievement transformation is igniting the trend of the plain across the country; From the content point of view, many regions have combined the spirit of the central document with the characteristics of regional development, such as Hebei issued policies to encourage the transfer and transformation of Beijing-Tianjin scientific and technological achievements in Hebei, and built a "Beijing-Tianjin R&D, Hebei transformation" model, giving full play to its location advantages
.
of wide distribution, rich layers and blooming flowers.
In particular, more and more local governments have noticed that the basic and cutting-edge characteristics of life medicine research, high investment, high risk, and long cycle, put forward higher requirements
for the accuracy, effectiveness and inclusiveness of policies.
Therefore, in the policies to be introduced in 2022, Beijing, Shanghai and other places have clarified a number of special policies for the transformation of medical science and technology, so as to give full play to the vanguard role
of medical research institutions in the process of achieving pharmaceutical innovation and development.
role of medical research institutions in the process of realizing the development of pharmaceutical innovation.
In 2022, the central government will issue relevant policies for the transformation of scientific and technological achievements, in addition to the Ministry of Science and Technology and the Intellectual Property Bureau, the Ministry of Education, the Health Commission, the State-owned Assets Supervision and Administration Commission and other departments will make concerted efforts, and talents, factor markets, intellectual property rights, etc.
have become high-frequency keywords
.
Important medical technology transformation policies in some regions in 2022 (in no particular order).
From the perspective of policy space, university research institutes are key areas, and medical institutions and technological innovation centers have become new development points; From the perspective of form, optimizing the evaluation mechanism of scientific and technological achievements, strengthening the transfer and transformation services of scientific and technological achievements, and reforming the evaluation method of professional titles have become key priorities
.
2.
Four significant trends in pharmaceutical technology transformation policies in 2022
1 Financial support: Early R&D guidance funds come into play
Financial support: Early R&D guidance funds come into playIn the corresponding policies in 2022, Guangdong, Shandong, Heilongjiang and other places have clearly given direct subsidies to enterprises that successfully carry out the transformation of achievements in relevant planning policies, while enjoying preferential tax policies, and further opening up green channels
for innovative enterprises in the fields of loans and bonds.
for innovative enterprises in the fields of loans and bonds.
At the same time, some regions have also noticed that the power of funds cannot only stay at the back end
.
For a long time, more than 80% of China's total R&D investment has been spent on back-end trial development, basic research institutes have received funding disproportionate to their key position, incentives for late-stage results are not enough to support early-stage R&D, and high-tolerance patient capital and seed funding are lacking
.
In this regard, some regions have begun to explore the form
of science and technology innovation funds guided by the government and market-oriented operation.
For example, Beijing has set up a 30 billion yuan science and technology innovation fund of funds, of which 80% is invested in start-up projects in the original innovation and achievement transformation stage, and some of the funds will be invested for up to 15 years
.
In addition, the fund also strengthens the linkage with universities and research institutes to support the incubation and transformation
of high-tech achievements.
In October 2022, the Ministry of Science and Technology and other six ministries and commissions issued the Notice on Allowing Central Universities, Scientific Research Institutions, Enterprises and Institutions to Apply < Beijing >Regulations on Promoting the Transformation of Scientific and Technological Achievements in the Core Area of Zhongguancun National Independent Innovation Demonstration Zone (Haidian Park), fully affirming Beijing's relevant policies
.
.
Some regions have begun to explore the form
of government-guided and market-oriented science and technology innovation funds.
80% of the investment is in the original innovation and achievement transformation stage of start-up projects, and part of the capital investment period is as long as 15 years
.
In addition, the fund also strengthens the linkage with universities and research institutes to support the incubation and transformation
of high-tech achievements.
2 Talent construction: break the inherent form of talent evaluation and training
Talent construction: break the inherent form of talent evaluation and trainingTalent incentives have always been an important concern
.
In 2022, Heilongjiang, Fujian, Chongqing and other places have further clarified the relevant policies for talent incentives, ensuring the benefits of the transformation of scientific researchers' achievements and the autonomy of patents, which plays an important role
in accelerating the transformation of achievements.
At the same time, the establishment of a title evaluation mechanism linked to the transformation of achievements has also been written into relevant policies
as an incentive mechanism.
in accelerating the transformation of achievements.
At the same time, the establishment of a title evaluation mechanism linked to the transformation of achievements has also been written into relevant policies
as an incentive mechanism.
In addition, the policy released in 2022 not only expands the concept of scientific and technological talent evaluation, but also further pays attention to the training mechanism
of talents of different gradients 。 The "Work Plan on Carrying out the Pilot Project of Evaluation and Reform of Scientific and Technological Talents" issued by the Ministry of Science and Technology separately explores and evaluates four categories of talents, including undertaking major national research tasks, basic research, applied research and technology development, and social welfare research, and clarifies the scientific research orientation and achievement orientation of talents; The Ministry of Education and other relevant documents for scientific research talents in colleges and universities further clarify the cultivation
of high-level talent teams, leading talents, full-time scientific research teams and industry-education collaborative innovation talents, and other talent teams of different types and stages of development.
This series of policies starts from the source of compound and transformational talent construction, and focuses on the improvement
of talent innovation ability.
In 2022, the attention to technical managers in various places has become a major feature of talent policies, and Beijing, Shandong and other places have issued special policies as a key development direction, focusing on cultivating compound talents with strong professional capabilities, giving full play to the important connecting role of technical managers in the process of transformation of scientific and technological achievements, and opening up the key points
of the industrialization of scientific and technological achievements.
3 Expand the market: the technology element market is fully launched
Expand the market: the technology factor market is fully launchedCreating a smoother scientific and technological transformation platform and optimizing industrializable scientific and technological achievements has always been regarded as an important means to
optimize the resource market.
In the policies released by various regions in 2022, many highlights have also been reflected, such as innovating patent evaluation methods and establishing a technology exchange database of scientific and technological achievements
.
However, for the market-oriented reform of technological factors, the space for policy play is limited to the transformation of scientific and technological achievements, and compared with the monetization of technological elements and commodities, its rights and capitalization can solve the institutional dilemma
of technology-driven innovation from the entire system construction.
Under the guidance of the spirit of the relevant documents of the State Council, the "14th Five-Year Plan" special plan for the market of technical elements clarifies six major directions
for building a market for technical elements, such as improving the property rights system for scientific and technological achievements and strengthening the supply of high-quality scientific and technological achievements.
The market mechanism will not only act on the technology transfer and industrialization link, but also start from the root cause and give play to the decisive role
of the market in the allocation of technological factor resources.
This policy will play a key role
in the transformation and development of market-oriented scientific and technological achievements in the next few years.
of technology-driven innovation from the entire system construction.
The "14th Five-Year Plan" special plan for the market of technological elements specifies six major directions
for building a market for technical elements, such as improving the property rights system for scientific and technological achievements and strengthening the supply of high-quality scientific and technological achievements.
The market mechanism will not only act on the technology transfer and industrialization link, but also start from the root cause and give play to the decisive role
of the market in the allocation of technological factor resources.
4 Results-oriented source innovation, an important new direction of scientific and technological achievements transformation policy
Results-oriented source innovation, an important new direction of scientific and technological achievements transformation policyAttaching great importance to medical scientific research, developing early-stage R&D funds, building new mechanisms for talent training and evaluation, and improving the technology element market, looking at the policies for the transformation of scientific and technological achievements from the central to the local government in 2022, it presents a new direction
for the source layout of scientific and technological transformation.
As a national important instrument to protect people's health and national security and promote healthy economic development, the transformation of medical science and technology emphasizes the organic integration of the whole chain of basic research, clinical research and technology product research and innovation, and the relevant policies for the transformation of medical scientific and technological achievements need to focus more on expanding the "basic research and core technology supply path, national demand-driven research and innovation path"
.
of the source layout of scientific and technological transformation.
"Basic research and core technology supply path, national demand driven research and innovation path"
.
Figure 1: The stages of the transformation of medical scientific and technological achievements and the corresponding policy development points
Looking back at 2022, various policies for the transformation of scientific and technological achievements from the central to the local level have shown a positive side
.
In the recent Central Economic Conference, the economic development in 2023 was deployed, with special emphasis on the focus of science and technology policies on self-reliance and self-improvement, laying out and implementing a number of major national science and technology projects, improving the new national system, giving full play to the organizational role of the government in key core technology research, and highlighting the main position
of enterprise scientific and technological innovation.
The development of independent and self-reliant science and technology requires long-term policy layout and planning, unremitting impetus, and history to evaluate and give answers
.
2023 is opening, we look forward to being more active and vigorous, focusing on the long-term and benefiting from the release of future medical technology transformation policies, and also looking forward to hearing the sound of policy implementation, ushering in the vigorous spring
of innovation-driven all-round development.
Policy Research Center, China Association for the Promotion of Pharmaceutical Innovation
Policy Research Center, China Association for the Promotion of Pharmaceutical Innovation
Author: Wu Qiong Wenqian Analyst wuqwq@phirda.
com
com
Review proofreader: Zhang Zhijuan, Liu Fapeng
Review proofreader: Zhang Zhijuan, Liu FapengResources:
Resources:
1.
The conversion rate is less than 8%! Breaking the transformation of medical scientific and technological achievements, what are the new attempts First Finance and Economics
2022-1-19https://m.
yicai.
com/news/101295286.
html
The conversion rate is less than 8%! Breaking the transformation of medical scientific and technological achievements, what are the new attempts First Finance and Economics 2022-1-19https://m.
yicai.
com/news/101295286.
html
2.
Part II of the Series on Building China's Pharmaceutical Innovation Ecosystem:
Promoting Basic Research and Activating the Source of Innovation", China Association for the Promotion of Pharmaceutical Innovation (PhIRDA), China Association of Enterprises with Foreign Investment Drug Research and Development Industry Committee (RDPAC), June 2021
Part II of the Series on Building China's Pharmaceutical Innovation Ecosystem: Promoting Basic Research and Activating the Source of Innovation", China Association for the Promotion of Pharmaceutical Innovation (PhIRDA), China Association of Enterprises with Foreign Investment Drug Research and Development Industry Committee (RDPAC), June 2021
3.
The Information Office of the State Council held a press conference on the progress of scientific and technological innovation
The Information Office of the State Council held a press conference on the progress of scientific and technological innovation 4.
The Central Economic Work Conference was held, Xi Jinping, Li Keqiang, Li Qiang made important speeches Chinese the People's Government Network 2022-12-16 4.
The Central Economic Work Conference was held, Xi Jinping, Li Keqiang, Li Qiang made important speeches Chinese the People's Government Network 2022-12-16 5.
The transformation of medical scientific research achievements needs to "break through the five barriers" Artery.
com 2020-7-3 5.
The transformation of medical scientific research achievements needs to "break through the five barriers" Artery.
com 2020-7-3 6.
How to cultivate the technology factor market Outlook Issue 11, 2021 6.
How to cultivate the technology factor market Outlook Issue 11, 2021
